<--- Back to Details
First PageDocument Content
Data / Pharmacology / Clinical research / Evaluation methods / Medical statistics / Communications protocol / Statistics / Number needed to harm / Clinical trial / Science / Information / Epidemiology
Date: 2015-04-27 04:26:33
Data
Pharmacology
Clinical research
Evaluation methods
Medical statistics
Communications protocol
Statistics
Number needed to harm
Clinical trial
Science
Information
Epidemiology

Add to Reading List

Source URL: www.encepp.eu

Download Document from Source Website

File Size: 382,00 KB

Share Document on Facebook

Similar Documents

PROUD PROUD Participant Involvement meeting: Trial Design Date: Tuesday 9th September – 20.00 Venue: MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, Holborn, WC2B 6NH Contact person: Mitzy Gaf

DocID: 1vq4y - View Document

Clinical Review & Education JAMA | Special Communication Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols

DocID: 1vmrb - View Document

For immediate release March 21, 2017 Infectex Announces Positive Phase 2b-3 Clinical Trial Results of SQ109 for the Treatment of Multidrug-Resistant Pulmonary Tuberculosis Moscow, Russia and Rockville, MD, USA -- Infecte

DocID: 1vkmw - View Document

DEPARTMENT OF HEALTH DRUG OFFICE DRUG REGISTRATION AND IMPORT/EXPORT CONTROL DIVISION Guidance Notes on the Application for Certificate for Clinical Trial/Medicinal Test Background

DocID: 1vkj3 - View Document

CLINICAL TRIAL OUTCOME DATABASE (CTOD) Novartis RA: Longitudinal Model-Based Meta-Analysis in Rheumatoid Arthritis: An Application Toward Model-Based Drug Development Authors I Demin, B Hamren, O Luttringer, G Pillai and

DocID: 1vbDv - View Document